Investing.com - Dr. Reddy’s Labs ADR reported on Friday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Dr. Reddy’s Labs ADR announced earnings per share of 0.46 on revenue of 646M. Analysts polled by Investing.com anticipated EPS of 0.5187 on revenue of 656.25M.
Dr. Reddy’s Labs ADR shares are up 1.75% from the beginning of the year and are trading at 72.54 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% from the start of the year.
Dr. Reddy’s Labs ADR follows other major Healthcare sector earnings this month
Dr. Reddy’s Labs ADR's report follows an earnings beat by J&J on April 20, who reported EPS of 2.59 on revenue of 22.32B, compared to forecasts EPS of 2.34 on revenue of 21.98B.
Pfizer had beat expectations on May 4 with first quarter EPS of 0.93 on revenue of 14.58B, compared to forecast for EPS of 0.7759 on revenue of 13.65B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar